Open Label Extension Study of AMX0035 in Patients With ALS
Clinical trial NCT03488524 · COMPLETED
Trial details
- NCT number
- NCT03488524
- Sponsor
- Amylyx Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-29
- Primary completion
- 2021-03-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.